Phase 2 Trial of Retreatment With Lenalidomide and Dexamethasone for Patients With Relapsed Myeloma
Phase of Trial: Phase II
Latest Information Update: 21 Nov 2016
At a glance
- Drugs Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 17 Nov 2016 Status changed from active, no longer recruiting to completed.
- 10 Oct 2016 Planned primary completion date changed from 1 May 2016 to 1 May 2017.
- 07 Jan 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.